• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FRS
Click for more information
0.00% 1.2¢

FORRESTANIA RESOURCES LIMITED

Market Cap $1.941M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
FRS
Ann: Drill programme to follow up 49gt Au sample 		10/09/24 3 1.0K
10/09/24 Last post  onthenose Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
FRS
Ann: Withdrawal from Fe Option 		04/09/24 12 3.5K
04/09/24 Last post  Feeenix73 Comments Created with Sketch.  12  Views Created with Sketch.  3.5K 
FRS
Ann: Quarterly Activities/Appendix 5B Cash Flow Report 		04/09/24 2 2.0K
04/09/24 Last post  investor901 Comments Created with Sketch.  2  Views Created with Sketch.  2.0K 
FRS
Ann: Drilling completed at Koolyanobbing 		02/09/24 16 5.2K
02/09/24 Last post  Archieros Comments Created with Sketch.  16  Views Created with Sketch.  5.2K 
FRS
Ann: Drilling Program Underway at Koolyanobbing 		22/08/24 59 18K
22/08/24 Last post  Rozting Comments Created with Sketch.  59  Views Created with Sketch.  18K 
FRS
Recording of webinar 		16/08/24 29 8.6K
16/08/24 Last post  bthumar Comments Created with Sketch.  29  Views Created with Sketch.  8.6K 
FRS
Ann: Board Change 		04/08/24 1 1.2K
04/08/24 Last post  Rozting Comments Created with Sketch.  1  Views Created with Sketch.  1.2K 
FRS
Ann: Ceasing to be a substantial holder from FTL 		11/07/24 1 993
11/07/24 Last post  Rozting Comments Created with Sketch.  1  Views Created with Sketch.  993 

See All Discussions arrow Created with Sketch.

Timeline

Drill programme to follow up 49gt Au sample
10 Sep 09:19
 
Withdrawal from Fe Option
03 Sep 08:44
 
Drilling completed at Koolyanobbing
23 Aug 08:37
 
Quarterly Activities/Appendix 5B Cash Flow Report
31 Jul 18:44
 
Ceasing to be a substantial holder from FTL
11 Jul 16:07
 
Drilling Program Underway at Koolyanobbing
02 Jul 09:35
 
View More arrow Created with Sketch.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.

(20min delay)
Last
1.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $1.941M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
6 1271450 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 118148 2
View Market Depth
Last trade - 16.12pm 20/09/2024 (20 minute delay) ?
FRS (ASX) Chart

Top Stories

Catalina Resources kicks off aircore drilling at Laverton project on the hunt for gold, REEs

Catalina Resources has confirmed its latest drill run has kicked off on-site its Laverton Project in Western Australia's Northern Goldfields.
Tennant Minerals clocks high-grade gold, copper hits at Bluebird in the NT Tennant Minerals has unveiled the results of its latest drill campaign at its Bluebird project, posting "high-grade" copper and gold hits.
Develop Global appoints GR to get Woodlawn copper-zinc plant online mid-2025 Develop shares jumped just over 4% in lunchtime trades on Friday as the company sees mid-2025 Woodlawn start.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.